Skip to main content

Table 1 Clinical characteristics of 90 ACC patients from TCGA database

From: Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma

Variables

Number (percentage)

Vital status

 Alive

57 (63.3%)

 Dead

33 (36.7%)

Age

NA

Gender

 Male

30 (33.3%)

 Female

60 (66.7%)

Tumor Grade

NA

Clinical Stage

 Stage I

9 (10.0%)

 Stage II

44 (48.9%)

 Stage III

19 (21.1%)

 Stage IV

18 (20.0%)

T stage

 T1

9 (10.0%)

 T2

49 (54.4%)

 T3

11 (12.2%)

 T4

21 (23.4%)

M stage

NA

N stage

 N0

80 (88.9%)

 N1

10 (11.1%)

  1. ACC Adrenocortical carcinoma, NA not available